Kidney disease treatment is undergoing a transformation, driven by exciting new research that reveals the protective power of semaglutide in patients with type 2 diabetes. Semaglutide, a medication ...

The meta-analysis identified a significant association between treatment with semaglutide and risk for NAION (OR, 3.92; 95% ...

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer's, according to two large new studies.

Trials have shown that semaglutide can reduce major cardiovascular events, but the extent of tirzepatide’s heart protection ...

Please provide your email address to receive an email when new articles are posted on . Semaglutide further reduced risk for stroke vs. empagliflozin as treatment for diabetes. Dulaglutide’s impact on ...

Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin. Those are the ...

Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...

There are improved cardiovascular outcomes associated with semaglutide therapy in patients with overweight or obesity without diabetes.

The Delhi High Court has permitted Dr. Reddy’s Laboratories to manufacture Semaglutide drug and export the same to other ...

How Much Does Semaglutide Cost? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. You’ve probably heard of ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

Treating newly diagnosed Type 1 diabetes patients with semaglutide (trade names Ozempic, Wegovy and Rybelsus) may drastically reduce or even eliminate their need for injected insulin. Treating newly ...